Is your child currently experiencing UC flare-ups? Local Crohn’s disease (CD) trial is testing a potential new medication to see if it may reduce abdominal pain, mouth sores, rectal pain, malnutrition, and/or joint pain associated with UC.
If you’re concerned about how UC affects your child’s life, find out more about the Crohn’s disease (CD) trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child may be able to take part.

We are looking for children at least 2 years of age but under 18 to join a CD medical research study to help us discover more about treating CD and UC. If you are looking for a potential new treatment option for CD and UC or Crohn’s and ulcerative colitis (including associated symptoms such as fatigue, kidney stones, constant need to poop, malnutrition and/or joint pain), consider one of our trials. All eligible participants will receive no-cost study-related care and study medication. Your children at least 2 years of age but under 18 may be eligible to take part.

Your child may be eligible to take part in the trials if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child may be able to take part.

Is your child currently experiencing IBD flare-ups? Local CD study is testing a potential new medication to see if it may reduce weight loss, perianal fistula, diarrhea, weight loss, and/or joint pain associated with IBD.
If you’re concerned about how IBD affects your child’s life, find out more about the CD study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child may be able to take part.

We are looking for young people 2–17 years old to join a Crohn’s disease (CD) clinical research study to help us discover more about treating IBD. If you are looking for a potential new treatment option for IBD or Crohn’s and ulcerative colitis (including associated symptoms such as abdominal cramping, failure to thrive, cramps, malnutrition and/or eye pain), consider one of our studies. All eligible participants will receive no-cost study-related care and study medication. Your young people 2–17 years old may be eligible to take part.

Your child may be eligible to take part in the studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child qualifies.

Is your child currently experiencing moderate to severe Crohn’s disease flare-ups? Local CD clinical research is testing a potential new medication to see if it may reduce painful joints, reduced appetite, bloody stool, chronic fatigue, and/or liver disease associated with moderate to severe Crohn’s disease.
If you’re concerned about how moderate to severe Crohn’s disease affects your child’s life, find out more about the CD clinical research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child qualifies.

We are looking for 2–17 year olds to join a research to help us discover more about treating UC. If you are looking for a potential new treatment option for UC or moderate to severe ulcerative colitis (including associated symptoms such as diarrhea with blood and pus, fatigue, constant need to poop, malnutrition and/or anemia), consider one of our medical research studies. All eligible participants will receive no-cost study-related care and study medication. Your 2–17 years old may be eligible to take part.

Your child may be eligible to take part in the medical research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child is eligible.

Is your child currently experiencing moderate to severe IBD flare-ups? Local Crohn’s disease medical research study is testing a potential new medication to see if it may reduce recurrent diarrhea, joint pain, constant need to poop, weight loss, and/or eye pain associated with moderate to severe IBD.
If you’re concerned about how moderate to severe IBD affects your child’s life, find out more about the Crohn’s disease medical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child is eligible.

We are looking for young people 2 to 17 years old to join a Crohn’s disease (CD) clinical research study to help us discover more about treating Crohn’s. If you are looking for a potential new treatment option for Crohn’s or UC (including associated symptoms such as abdominal cramping, kidney stones, rectal pain, weight loss and/or eye pain), consider one of our IBD clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your young people 2 to 17 years old may be eligible to take part.

Your child may be eligible to take part in the IBD clinical trials if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

See if your child is eligible.

Is your child currently experiencing moderate to severe CD flare-ups? Local research study is testing a potential new medication to see if it may reduce fatigue, fatigue, diarrhea, chronic fatigue, and/or anemia associated with moderate to severe CD.
If you’re concerned about how moderate to severe CD affects your child’s life, find out more about the research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child is eligible.

We are looking for children and teenagers 2–17 years of age to join a clinical research to help us discover more about treating IBD. If you are looking for a potential new treatment option for IBD or Crohn’s and UC (including associated symptoms such as diarrhea with blood, weight loss, constant need to poop, malnutrition and/or eye pain), consider one of our clinical research. All eligible participants will receive no-cost study-related care and study medication. Your children and teenagers 2–17 years of age may be eligible to take part.

Your child may be eligible to take part in the clinical research if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Act now.